GO:0051151 negative regulation of smooth muscle cell differentiation: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051151 describes any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell differentiation.
• Smooth muscle cell differentiation is controlled by a network of transcription factors, including KLF4, OCT4, and SMAD7, which can repress the differentiated state.
• Redox signaling and autophagy influence the balance between proliferation and differentiation of smooth muscle cells.
• Negative regulation of smooth muscle cell differentiation is critical in vascular diseases such as atherosclerosis and vascular calcification.
• Key experimental approaches to study this process include knockout, point mutation, knock-in, and overexpression models, often combined with transcriptomics and imaging.
• Understanding this GO term helps identify therapeutic targets for diseases characterized by abnormal smooth muscle cell plasticity.
Description
Smooth muscle cells (SMCs) are essential for the function of blood vessels, the gastrointestinal tract, and other organs. Their differentiation from progenitors is a tightly regulated process that, when disrupted, contributes to a range of pathologies. The Gene Ontology (GO) term GO:0051151, negative regulation of smooth muscle cell differentiation, captures the biological processes that inhibit or reduce the extent of SMC differentiation. This term is of broad interest because SMC phenotypic modulation is a hallmark of vascular remodeling, atherosclerosis, and other diseases. Researchers studying development, vascular biology, and regenerative medicine need to understand the molecular players that suppress SMC differentiation. This article synthesizes authoritative GO annotations and published literature to provide a research-grade overview of GO:0051151, its mechanisms, key genes, and experimental models.
negative regulation of smooth muscle cell differentiation At A Glance
| GO ID | GO:0051151 |
|---|---|
| GO term | negative regulation of smooth muscle cell differentiation |
| Ontology | biological_process |
| Synonym | down regulation of smooth muscle cell differentiation, down-regulation of smooth muscle cell differentiation, downregulation of smooth muscle cell differentiation, inhibition of smooth muscle cell differentiation |
| Major function | Inhibition or reduction of the frequency, rate, or extent of smooth muscle cell differentiation |
| Related processes | Smooth muscle cell differentiation (GO:0051145), regulation of smooth muscle cell differentiation (GO:0051150) |
| Cellular context | Vascular smooth muscle cells, airway smooth muscle cells, gastrointestinal smooth muscle cells |
| Key regulators | KLF4, OCT4, SMAD7, redox-sensitive pathways, autophagy-related proteins |
What Is GO:0051151?
GO:0051151 is defined as any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell differentiation. In other words, it encompasses molecular events that actively inhibit the transition of precursor cells into mature, contractile smooth muscle cells. This negative regulation can occur through transcriptional repression, signaling cascades, or epigenetic modifications that block the expression of smooth muscle-specific genes.
Why Is negative regulation of smooth muscle cell differentiation Important in Cell Biology?
Negative regulation of smooth muscle cell differentiation is crucial for understanding how SMCs switch between contractile and synthetic phenotypes. This plasticity is central to vascular development, injury response, and diseases such as atherosclerosis, where SMCs dedifferentiate and contribute to plaque formation. Moreover, factors that inhibit SMC differentiation can promote fibrosis or calcification, making this process a therapeutic target. Studying GO:0051151 helps researchers identify molecular brakes on SMC differentiation and develop strategies to modulate them in disease settings.
• Controls SMC phenotypic switching in atherosclerosis and restenosis.
• Influences vascular calcification through BMP2 signaling.
• Modulates cardiac fibrosis and remodeling after pressure overload.
• Involved in redox-dependent regulation of SMC differentiation.
• Autophagy and mTORC2 signaling affect fibroblast senescence and may impact SMC differentiation.
• KLF4 and OCT4 are pluripotency factors that repress SMC differentiation in late-stage atherosclerotic lesions.
• SMAD7 induction in fibroblasts protects the heart by modulating TGF-beta signaling.
• Sfrp1 inhibits fibroblast invasion and may influence myofibroblast transition, a process related to SMC differentiation.
• Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis, highlighting the role of stromal cells in differentiation control.
• NONO attenuates vascular calcification by inhibiting BMP2 transcription, linking paraspeckle proteins to SMC differentiation.
What Happens During negative regulation of smooth muscle cell differentiation?
Transcriptional repression of SMC-specific genes
In simple terms: Certain proteins act as brakes that stop the cell from turning on smooth muscle genes.
Negative regulation of SMC differentiation often involves transcription factors that bind to and repress the promoters of smooth muscle-specific genes, such as ACTA2, MYH11, and TAGLN. For example, KLF4 and OCT4, which are pluripotency-associated factors, can suppress SMC differentiation programs in atherosclerotic lesions. Similarly, SMAD7 induction in fibroblasts modulates TGF-beta signaling and protects the pressure-overloaded heart, indicating that transcriptional repressors can block differentiation-associated gene expression.
Redox-dependent inhibition
In simple terms: Changes in the cell's oxidative state can send signals that prevent smooth muscle cells from maturing.
Redox regulation plays a significant role in controlling SMC differentiation. Reactive oxygen species and antioxidant pathways can modulate the activity of transcription factors and kinases that inhibit differentiation. Su et al. demonstrated that redox status regulates vascular SMC differentiation, with oxidative stress promoting a dedifferentiated phenotype. This suggests that negative regulation of SMC differentiation can be mediated by redox-sensitive signaling cascades.
Autophagy and mTORC2 signaling
In simple terms: The cell's recycling system and a growth-signaling pathway can influence whether smooth muscle cells differentiate.
Autophagy and mTORC2 have been implicated in fibroblast senescence and differentiation. Bernard et al. showed that autophagy drives fibroblast senescence through MTORC2 regulation. Although this study focused on fibroblasts, similar mechanisms may operate in SMCs, where autophagic flux and mTORC2 activity could inhibit differentiation. This highlights a broader role for metabolic and degradative pathways in negative regulation of SMC differentiation.
Extracellular matrix and secreted factors
In simple terms: Proteins outside the cell can send stop signals that keep smooth muscle cells from specializing.
Secreted factors such as Sfrp1 and Meflin can modulate the tissue microenvironment and influence differentiation. Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts, and Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis. These findings suggest that extracellular cues can negatively regulate differentiation processes, potentially including SMC differentiation, by altering cell-matrix interactions and paracrine signaling.
Paraspeckle proteins and BMP2 transcription
In simple terms: Specialized nuclear structures can block the production of a protein that promotes calcification and differentiation.
The paraspeckle protein NONO attenuates vascular calcification by inhibiting bone morphogenetic protein 2 (BMP2) transcription. Since BMP2 signaling promotes osteogenic differentiation of SMCs, its repression by NONO represents a mechanism of negative regulation of SMC differentiation. This links nuclear RNA-protein complexes to the control of SMC phenotype.
Key Genes Involved in GO:0051151 negative regulation of smooth muscle cell differentiation
The following genes and proteins have been experimentally linked to the negative regulation of smooth muscle cell differentiation or related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KLF4 | Transcription factor that represses SMC differentiation | Pluripotency factor; promotes phenotypic modulation in atherosclerosis |
| OCT4 | Transcription factor that represses SMC differentiation | Pluripotency factor; co-regulates SMC phenotypic changes |
| SMAD7 | Inhibitory SMAD that blocks TGF-beta signaling | Protects pressure-overloaded heart; may inhibit SMC differentiation |
| NONO | Paraspeckle protein that inhibits BMP2 transcription | Attenuates vascular calcification; negative regulator of osteogenic differentiation |
| SFRP1 | Secreted Wnt antagonist | Inhibits fibroblast invasion; may influence myofibroblast transition |
| MEFLIN | Transmembrane protein in fibroblasts | Marker of cancer-associated fibroblasts; inhibits carcinogenesis |
| MTOR | Kinase in mTORC2 complex | Regulates autophagy and senescence; potential role in SMC differentiation |
| ACTA2 | Smooth muscle alpha-actin | Contractile marker; its repression indicates negative regulation of differentiation |
| MYH11 | Smooth muscle myosin heavy chain | Contractile marker; downregulated during dedifferentiation |
| TAGLN | SM22-alpha, smooth muscle protein | Contractile marker; used to assess SMC differentiation status |
| BMP2 | Bone morphogenetic protein 2 | Promotes osteogenic differentiation; inhibited by NONO |
| TGFB1 | Transforming growth factor beta 1 | Promotes SMC differentiation; inhibited by SMAD7 |
| KLF5 | Kruppel-like factor 5 | Modulates SMC phenotype; may interact with KLF4 |
| MYOCD | Myocardin | Coactivator of SRF; drives SMC differentiation; its inhibition leads to negative regulation |
| SRF | Serum response factor | Transcription factor cooperating with myocardin; target of negative regulation |
| ELN | Elastin | Extracellular matrix protein; influences SMC phenotype |
| COL1A1 | Collagen type I alpha 1 | Fibrotic marker; associated with SMC phenotypic modulation |
| CDKN1A | p21, cyclin-dependent kinase inhibitor | Cell cycle arrest; may accompany differentiation changes |
How Is negative regulation of smooth muscle cell differentiation Regulated?
The negative regulation of smooth muscle cell differentiation is itself controlled by multiple signaling pathways. TGF-beta signaling, through SMAD proteins, generally promotes SMC differentiation; thus, inhibitors such as SMAD7 can block this process. Redox-sensitive pathways, including those involving reactive oxygen species, can either promote or inhibit differentiation depending on context. Autophagy and mTORC2 signaling have been shown to regulate fibroblast senescence and may similarly influence SMC differentiation. Additionally, transcription factors like KLF4 and OCT4 can be induced under pathological conditions to repress the SMC differentiation program. These regulatory layers ensure that SMC differentiation is dynamically controlled in response to environmental cues.
negative regulation of smooth muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KLF4 | Atherosclerosis | SMC-specific KLF4 knockout mouse; overexpression in SMCs |
| OCT4 | Atherosclerosis | Inducible OCT4 overexpression in SMCs |
| SMAD7 | Cardiac fibrosis | Fibroblast-specific SMAD7 knockout or overexpression |
| NONO | Vascular calcification | NONO knockout in vascular SMCs; BMP2 reporter assays |
| SFRP1 | Lung fibrosis | Sfrp1 knockout mice; fibroblast invasion assays |
Atherosclerosis and vascular remodeling
In atherosclerosis, smooth muscle cells undergo phenotypic switching from a contractile to a synthetic state, contributing to plaque formation and instability. Negative regulation of SMC differentiation is a key mechanism driving this switch. KLF4 and OCT4 are upregulated in late-stage atherosclerotic lesions and repress SMC differentiation genes, promoting disease progression. Targeting these negative regulators could stabilize plaques.
Vascular calcification
Vascular calcification involves the osteogenic differentiation of SMCs, which is normally inhibited by factors such as NONO. NONO attenuates vascular calcification by inhibiting BMP2 transcription. Loss of NONO function leads to increased BMP2 expression and enhanced calcification, demonstrating that negative regulation of SMC differentiation is protective in this context.
Cardiac fibrosis and heart failure
Fibroblast activation and myofibroblast differentiation contribute to cardiac fibrosis. SMAD7 induction in fibroblasts protects the pressure-overloaded heart by inhibiting TGF-beta signaling. Although this study focuses on fibroblasts, similar mechanisms may apply to SMCs, where negative regulation of differentiation could prevent excessive fibrosis.
Cancer-associated fibroblasts
Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis. These fibroblasts may represent a differentiated state that opposes tumor progression. Negative regulation of differentiation in stromal cells could therefore influence cancer outcomes, highlighting the broader relevance of GO:0051151.
From negative regulation of smooth muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X repress SMC differentiation? | CRISPR knockout of gene X in SMC lines or primary SMCs, followed by differentiation assays |
| Does a point mutation in gene Y affect its repressive function? | CRISPR point mutation knock-in of the mutation in SMCs |
| Does overexpression of gene Z inhibit SMC differentiation? | Lentiviral overexpression of gene Z in SMCs |
| Where is protein X localized during negative regulation? | Tagged knock-in of gene X with fluorescent protein |
| What transcriptional networks are altered? | RNA-seq after CRISPR knockout or overexpression |
| Does autophagy modulate SMC differentiation? | ATG5 or ATG7 knockout in SMCs; autophagy flux assays |
How to Study the negative regulation of smooth muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify SMC differentiation genes repressed by KLF4/OCT4 |
| ChIP-seq | Transcription factor binding sites | Map KLF4 binding to SMC gene promoters |
| Co-IP / mass spectrometry | Protein-protein interactions | Study SMAD7 interactions with TGF-beta receptors |
| Immunofluorescence | Protein localization and expression | Visualize ACTA2 and NONO in SMCs |
| Western blot | Protein levels and modifications | Assess SMAD7 induction and TGF-beta signaling |
| Autophagy flux assay | Autophagic activity | Determine role of autophagy in SMC differentiation |
| CRISPR screen | Genes affecting SMC differentiation | Identify novel negative regulators |
| Reporter assays | Transcriptional activity | Measure BMP2 promoter inhibition by NONO |
Transcriptomic profiling (RNA-seq)
RNA sequencing allows global assessment of gene expression changes when negative regulators of SMC differentiation are manipulated. For example, knockout of KLF4 or OCT4 in SMCs followed by RNA-seq can reveal downstream targets and pathways. This method is essential for identifying SMC-specific contractile genes that are repressed.
Protein interaction and modification assays
Co-immunoprecipitation, Western blotting, and mass spectrometry can identify protein complexes involving negative regulators. For instance, SMAD7 interactions with TGF-beta receptors can be studied by co-IP. Phosphorylation and ubiquitination events can be detected with specific antibodies.
Imaging of SMC phenotype
Immunofluorescence and live-cell imaging using tagged proteins (e.g., GFP-tagged NONO) can visualize localization and expression of differentiation markers. Smooth muscle alpha-actin (ACTA2) staining is commonly used to assess differentiation status. High-content imaging can quantify phenotypic changes in response to genetic perturbations.
Functional differentiation assays
In vitro differentiation assays using primary SMCs or induced pluripotent stem cell-derived SMCs can measure contractility, proliferation, and expression of SMC markers. These assays are used to test whether a gene negatively regulates differentiation. For example, overexpression of KLF4 in SMCs reduces ACTA2 expression.
How CRISPR Can Be Used to Study GO:0051151 negative regulation of smooth muscle cell differentiation
Knockout
CRISPR knockout is used to delete candidate negative regulators of SMC differentiation, such as KLF4, OCT4, or NONO, to assess whether their loss enhances differentiation. For example, knockout of KLF4 in SMCs leads to increased expression of contractile markers. Knockout of NONO results in increased BMP2 transcription and vascular calcification.
Point Mutation
Point mutations can be introduced to dissect specific functional domains or phosphorylation sites. For instance, mutating the DNA-binding domain of KLF4 can test its role in repressing SMC genes. Point mutations in SMAD7 can reveal residues critical for inhibiting TGF-beta signaling.
Knock-in
Knock-in of tagged versions of proteins (e.g., GFP-NONO) allows tracking of endogenous protein localization and dynamics. Knock-in of reporter genes under the control of SMC-specific promoters can monitor differentiation in real time. This approach is valuable for studying negative regulation in live cells.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high levels of candidate negative regulators to test their sufficiency in blocking SMC differentiation. Overexpression of KLF4 or OCT4 in SMCs represses contractile gene expression. Overexpression of SMAD7 in fibroblasts protects against cardiac fibrosis.
How EDITGENE Supports negative regulation of smooth muscle cell differentiation Research
Researchers studying negative regulation of smooth muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in repressing the differentiated state. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides comprehensive services to support such studies, from cell line generation to functional screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of smooth muscle cell differentiation research.
Frequently Asked Questions About negative regulation of smooth muscle cell differentiation
What is GO:0051151?
GO:0051151 is the Gene Ontology term for negative regulation of smooth muscle cell differentiation, defined as any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell differentiation.
What genes are involved in negative regulation of smooth muscle cell differentiation?
Key genes include KLF4, OCT4, SMAD7, NONO, and SFRP1, among others.
How is negative regulation of smooth muscle cell differentiation studied?
Researchers use CRISPR knockout, overexpression, RNA-seq, imaging, and functional differentiation assays to study this process.
Why is negative regulation of smooth muscle cell differentiation important in atherosclerosis?
In atherosclerosis, factors like KLF4 and OCT4 repress SMC differentiation, promoting a synthetic phenotype that contributes to plaque formation.
What role does NONO play in vascular calcification?
NONO inhibits BMP2 transcription, thereby attenuating vascular calcification and osteogenic differentiation of SMCs.
Can autophagy affect smooth muscle cell differentiation?
Autophagy and mTORC2 signaling influence fibroblast senescence and may similarly modulate SMC differentiation.
What is the role of SMAD7 in smooth muscle cell differentiation?
SMAD7 inhibits TGF-beta signaling, which generally promotes SMC differentiation, thus acting as a negative regulator.
How does redox signaling regulate smooth muscle cell differentiation?
Redox-sensitive pathways can inhibit SMC differentiation by modulating transcription factors and kinases.
What experimental models are used to study negative regulation of SMC differentiation?
Common models include CRISPR knockout and overexpression in SMC lines, primary SMCs, and mouse models.
What services does EDITGENE offer for studying GO:0051151?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics analysis.
Conclusion
GO:0051151, negative regulation of smooth muscle cell differentiation, is a critical biological process that controls SMC phenotypic plasticity. Dysregulation of this process contributes to atherosclerosis, vascular calcification, and fibrosis. Key molecular players include KLF4, OCT4, SMAD7, and NONO, which repress differentiation through transcriptional and signaling mechanisms. Advances in CRISPR-based models and high-throughput methods are accelerating our understanding of this process. EDITGENE offers a comprehensive suite of services to support researchers in dissecting the negative regulation of SMC differentiation and translating findings into therapeutic strategies.
References
- 1. Mayr CH et al.. 2024. Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts.. Eur Respir J 63(2) PMID: 38212077
- 2. Bernard M et al.. 2020. Autophagy drives fibroblast senescence through MTORC2 regulation.. Autophagy 16(11):2004-2016 PMID: 31931659
- 3. Mizutani Y et al.. 2019. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.. Cancer Res 79(20):5367-5381 PMID: 31439548
- 4. Lu Y et al.. 2024. Paraspeckle protein NONO attenuates vascular calcification by inhibiting bone morphogenetic protein 2 transcription.. Kidney Int 105(6):1221-1238 PMID: 38417578
- 5. Owens GK et al.. 1996. Molecular regulation of smooth muscle cell differentiation.. J Hypertens Suppl 14(5):S55-64 PMID: 9120686
- 6. Humeres C et al.. 2024. Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart.. Circ Res 135(3):453-469 PMID: 38899461
- 7. Su B et al.. 2001. Redox regulation of vascular smooth muscle cell differentiation.. Circ Res 89(1):39-46 PMID: 11440976
- 8. Alencar GF et al.. 2020. Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis.. Circulation 142(21):2045-2059 PMID: 32674599
